FDA clears icometrix’ image quantification software to monitor neurological disorders

After opening a subsidiary in the Boston area earlier this year, Belgian health tech company icometrix has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their image quantification software, icobrain. icobrain quantifies key features of clinical MRI brain scans, which enable clinicians to monitor how their patient’s brain changes over time.